Kala Bio and Virotek sign non-binding LOI to expand genetic testing

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/8/2026

1. MRVL
2. ZS
3. PENG
4. STZ
5. NVDA
6. MSFT
7. SPY
8. SKYD
9. RCKT
10. IBM

Go back to Kala Bio and Virotek sign non-binding LOI to expand genetic testing

Kala Bio and Virotek Sign Letter of Intent with U.S. DNA Testing Platform to Resell Virotek's Suite of Genetic Testing Products

September 24, 2026 7:30 AM EDT

Agreement would expand the companies' genetic testing collaboration beyond ophthalmology to a selected suite of genomic testing products through an additional U.S. reseller channel

ARLINGTON, Mass., Sept. 24, 2026 (GLOBE NEWSWIRE) -- Kala Bio, Inc. (Nasdaq: KALA) ("Kala") and Virotek Inc. ("Virotek") today announced that they have signed a non-binding letter of intent (the "LOI") with a U.S. DNA testing platform under which the platform would resell Virotek's selected suite of genomic testing products. The mechanics of the commercial and economic terms are being finalized. Assuming negotiations are... More